Iconic Labs Plc ("Iconic Labs" or the "Company")
Results of AGM
Iconic Labs plc (AIM: ICON), a multi-divisional new media and technology business, advises that it held its Annual General Meeting ("AGM") on 31st December 2020.
All resolutions were duly passed on a poll vote, with the exception of resolutions 8 and 9.
Details of the proxy voting are shown in the table below.
|
Ordinary resolutions |
Votes For |
% |
Votes Against |
% |
Votes Total |
Votes Withheld |
|
1. Annual report and accounts |
2,438,131,706 |
72.2% |
940,030,000 |
27.8% |
3,378,161,706 |
- |
|
2. Directors' remuneration report |
2,381,589,539 |
70.5% |
979,288,670 |
29.0% |
3,378,161,706 |
17,283,497 |
|
3. Reappointment of directors (Liam Harrington) |
2,375,239,672 |
70.3% |
1,002,905,084 |
29.7% |
3,378,161,706 |
16,950 |
|
4. Reappointment of directors (Katharine Lewis) |
2,395,759,198 |
70.9% |
982,385,558 |
29.1% |
3,378,161,706 |
16,950 |
|
5. Re-appointment of auditors |
2,432,434,510 |
72.0% |
945,680,246 |
28.0% |
3,378,161,706 |
46,950 |
|
6. Remuneration of auditors |
2,416,935,877 |
71.5% |
961,225,829 |
28.5% |
3,378,161,706 |
- |
|
7. Allotment of Shares |
1,698,250,476 |
50.3% |
1,679,911,230 |
49.7% |
3,378,161,706 |
- |
|
Special Resolutions |
||||||
|
8. Empowering the directors' to disapply statutory pre-emption rights |
1,697,355,094 |
50.2% |
1,680,806,612 |
49.8% |
3,378,161,706 |
- |
|
9. Purchase by the Company of its own shares |
2,409,770,834 |
71.3% |
968,390,872 |
28.7% |
3,378,161,706 |
- |
The full text of each of the resolutions is set out in the Notice of AGM, available on the Company's website ( www.iconiclabs.co.uk )
Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
**ENDS**
For further information, please visit the Company's website www.iconiclabs.co.uk or contact:
|
Damon Heath |
Shard Capital Partners LLP |
Tel: +44 (0) 20 7186 9950 |
Iconic Labs ir@iconiclabs.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.